4 Lupus Clinical Trials in Denver, CO (2026)

Q: How do I join a clinical trial in Denver?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you.

Recruiting Lupus Studies in Denver

NCT07409181Recruiting

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

This study is open to adults with systemic lupus erythematosus (SLE). The purpose of this study is to find out whether a medicine called BI 3000202 helps people with SLE. The study tests different dos...

Denver, COPHASE2405 participantsBoehringer Ingelheim

View Study Details

NCT05869955Recruiting

A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

The purpose of this study is to establish the tolerability, preliminary efficacy, and pharmacokinetics of CC-97540 in participants with severe, refractory autoimmune diseases (Breakfree-1)....

Denver, COPHASE1270 participantsJuno Therapeutics, Inc., a Bristol-Myers Squibb Company

View Study Details

NCT07015983Recruiting

A Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

The purpose of this study is to evaluate the efficacy, safety and drug levels of CC-97540 in participants with active systemic lupus erythematosus (SLE) including lupus nephritis with inadequate respo...

Denver, COPHASE289 participantsJuno Therapeutics, Inc., a Bristol-Myers Squibb Company

View Study Details

NCT07403188Recruiting

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

The purpose of this long-term follow-up (LTFU) study is to collect delayed adverse events (AEs) and understand the persistence of KYV-101 (autologous CAR T cell product; gene-modified product), in par...

Denver, CO70 participantsKyverna Therapeutics

View Study Details

About Lupus Clinical Trials in Denver

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.

There are currently 4 lupus clinical trials recruiting participants in Denver, CO. These studies are seeking a combined 834 participants. Research is being sponsored by Boehringer Ingelheim, Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, Kyverna Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lupus Clinical Trials in Denver — FAQ

Are there lupus clinical trials in Denver?

Yes, there are 4 lupus clinical trials currently recruiting in Denver, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Denver?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you about next steps.

Are clinical trials in Denver free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Denver studies also compensate for your time and travel.

What lupus treatments are being tested?

The 4 active trials in Denver are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.

Data updated July 18, 2026 from ClinicalTrials.gov